• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓系来源的抑制细胞的早期激活通过 PD-L1/PD-1 轴参与脓毒症诱导的免疫抑制。

Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.

机构信息

Department of Emergency Medicine, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.

Department of Geriatrics, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.

出版信息

Front Immunol. 2020 Jul 3;11:1299. doi: 10.3389/fimmu.2020.01299. eCollection 2020.

DOI:10.3389/fimmu.2020.01299
PMID:32719675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7347749/
Abstract

Myeloid derived suppressor cells (MDSCs) have been reported to keep elevating during sepsis. The current study was performed to investigate the immunosuppressive effect of MDSCs and their subsets with the underlying mechanisms. The immunosuppressive status was manifested by the apoptosis of splenocytes, quantity of T cells and PD-1 expression. The dynamics of quantity and PD-L1 level of MDSCs and the subsets were determined over time. The subset of MDSCs with high PD-L1 level was co-cultured with T cells to observe the suppressive effect. Abdominal abscess was observed after 7 days post-sepsis. Five biomarkers related to organ functions were all significantly higher in the CLP group. The survival rate was consistent with the middle grade severity of sepsis model. Apoptosis of splenocytes increased over time during sepsis; CD4 + T cell decreased from day 1 post-sepsis; CD8+ T cells significantly reduced at day 7. The PD-1 expression in spleen was upregulated from an early stage of sepsis, and negatively related with the quantity of T cells. MDSCs were low at day 1 post-sepsis, but increased to a high level later; the dynamics of PMN-MDSC was similar to MDSCs. PD-L1 on MDSCs was highest at day 1 post-sepsis; PMN-MDSC was the main subset expressing PD-L1. The PMN-MDSC with high PD-L1 expression level extracted on day 1 after surgery from CLP mice significantly inhibited the proliferation of T cells. Sepsis-induced immunosuppression is initiated from a very early stage, a high expression level of PD-L1 on MDSCs and the main subset, PMN-MDSC might play a critical role suppressive role on T cells through PD-L1/PD-1 axis.

摘要

髓系来源的抑制细胞(MDSCs)在脓毒症中一直被报道呈升高趋势。本研究旨在探讨 MDSCs 及其亚群的免疫抑制作用及其潜在机制。免疫抑制状态表现为脾细胞凋亡、T 细胞数量和 PD-1 表达减少。随着时间的推移,MDSCs 和其亚群的数量和 PD-L1 水平的动态变化被确定。具有高 PD-L1 水平的 MDSC 亚群与 T 细胞共培养,观察其抑制作用。脓毒症 7 天后观察到腹部脓肿。CLP 组的 5 种与器官功能相关的生物标志物均显著升高。存活率与中重度脓毒症模型一致。脓毒症过程中脾细胞凋亡随时间增加;CD4+T 细胞从脓毒症后第 1 天开始减少;CD8+T 细胞在第 7 天显著减少。脾 PD-1 表达在脓毒症早期上调,并与 T 细胞数量呈负相关。MDSCs 在脓毒症后第 1 天数量较低,但随后增加到高水平;PMN-MDSC 的动态变化与 MDSCs 相似。MDSCs 上的 PD-L1 在脓毒症后第 1 天表达最高;PMN-MDSC 是表达 PD-L1 的主要亚群。从 CLP 小鼠手术后第 1 天提取的高表达 PD-L1 的 PMN-MDSC 显著抑制了 T 细胞的增殖。脓毒症诱导的免疫抑制是从一个非常早期的阶段开始的,MDSCs 上高表达的 PD-L1 和主要亚群 PMN-MDSC 通过 PD-L1/PD-1 轴可能对 T 细胞发挥关键的抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/577fbe938719/fimmu-11-01299-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/a97018d7310e/fimmu-11-01299-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/d5cf048cbce2/fimmu-11-01299-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/c9da38703e84/fimmu-11-01299-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/79a4da1fe494/fimmu-11-01299-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/6d9dcd29224f/fimmu-11-01299-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/39f76769c5a5/fimmu-11-01299-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/751921328dc9/fimmu-11-01299-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/577fbe938719/fimmu-11-01299-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/a97018d7310e/fimmu-11-01299-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/d5cf048cbce2/fimmu-11-01299-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/c9da38703e84/fimmu-11-01299-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/79a4da1fe494/fimmu-11-01299-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/6d9dcd29224f/fimmu-11-01299-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/39f76769c5a5/fimmu-11-01299-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/751921328dc9/fimmu-11-01299-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/7347749/577fbe938719/fimmu-11-01299-g0008.jpg

相似文献

1
Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.髓系来源的抑制细胞的早期激活通过 PD-L1/PD-1 轴参与脓毒症诱导的免疫抑制。
Front Immunol. 2020 Jul 3;11:1299. doi: 10.3389/fimmu.2020.01299. eCollection 2020.
2
Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.程序性死亡配体 1 表达增强系统性红斑狼疮中髓源性抑制细胞的免疫调节功能。
Front Immunol. 2021 Apr 27;12:606024. doi: 10.3389/fimmu.2021.606024. eCollection 2021.
3
Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis.人脾髓源抑制性细胞:表型和聚类分析。
Cell Immunol. 2021 May;363:104317. doi: 10.1016/j.cellimm.2021.104317. Epub 2021 Mar 1.
4
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.通过靶向脂肪酸转运蛋白 2 调节髓源性抑制细胞中的 ROS 增强抗 PD-L1 肿瘤免疫治疗。
Cell Immunol. 2021 Apr;362:104286. doi: 10.1016/j.cellimm.2021.104286. Epub 2021 Jan 19.
5
Polymorphonuclear Myeloid-Derived Cells That Contribute to the Immune Paralysis Are Generated in the Early Phase of Sepsis via PD-1/PD-L1 Pathway.中性粒细胞髓样来源的细胞通过 PD-1/PD-L1 通路在脓毒症早期产生,有助于免疫麻痹。
Infect Immun. 2021 May 17;89(6). doi: 10.1128/IAI.00771-20.
6
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.组氨酸靶向髓系来源的抑制细胞,提高 PD-1/PD-L1 检查点阻断的抗肿瘤疗效。
Cancer Immunol Immunother. 2019 Feb;68(2):163-174. doi: 10.1007/s00262-018-2253-6. Epub 2018 Oct 12.
7
The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients.稳定期 COPD 患者外周血中程序性死亡受体-1/PD-L1 轴、髓系来源的抑制细胞亚群和调节性 T 细胞的临床相关性。
PeerJ. 2024 Mar 27;12:e16988. doi: 10.7717/peerj.16988. eCollection 2024.
8
Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.通过 IRF8 表达的多模式瘤内治疗重塑抗 PD-L1 治疗耐药的髓系细胞 compartment
J Immunol. 2021 Sep 1;207(5):1298-1309. doi: 10.4049/jimmunol.2100281. Epub 2021 Aug 6.
9
Modulation of PD-1/PD-L1 axis in myeloid-derived suppressor cells by anti-cancer treatments.抗癌治疗对髓源性抑制细胞中 PD-1/PD-L1 轴的调节。
Cell Immunol. 2021 Apr;362:104301. doi: 10.1016/j.cellimm.2021.104301. Epub 2021 Feb 4.
10
Splenectomy provides protective effects against CLP-induced sepsis by reducing TRegs and PD-1/PD-L1 expression.脾切除术通过减少 TRegs 和 PD-1/PD-L1 的表达,对 CLP 诱导的脓毒症提供保护作用。
Int J Biochem Cell Biol. 2021 Jul;136:105970. doi: 10.1016/j.biocel.2021.105970. Epub 2021 Mar 24.

引用本文的文献

1
Pharmacological and genetic inhibition of ARG2 in CXCR2 myeloid-derived suppressor cells combats sepsis-induced lymphopenia.对CXCR2骨髓来源的抑制性细胞中的精氨酸酶2进行药理学和基因抑制可对抗脓毒症诱导的淋巴细胞减少。
Theranostics. 2025 Jul 11;15(16):7990-8011. doi: 10.7150/thno.112339. eCollection 2025.
2
The role of PD-1/PD-L1 in overshooting osteoclastogenesis in periprosthetic joint infections.PD-1/PD-L1在人工关节周围感染中破骨细胞生成过度中的作用。
Commun Biol. 2025 May 22;8(1):786. doi: 10.1038/s42003-025-08143-3.
3
Insights into sepsis-induced apoptosis: Interplay between programmed cell death and interleukin-7.

本文引用的文献

1
Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling.应急性髓系造血有助于免疫细胞衰竭和肺血管重塑。
Br J Pharmacol. 2021 Jan;178(1):187-202. doi: 10.1111/bph.14945. Epub 2020 Feb 4.
2
Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis.髓系来源的抑制性细胞功能和表观遗传表达在手术后脓毒症中随时间演变。
Crit Care. 2019 Nov 13;23(1):355. doi: 10.1186/s13054-019-2628-x.
3
Prospect of using deep learning for predicting differentiation of myeloid progenitor cells after sepsis.
脓毒症诱导的细胞凋亡研究进展:程序性细胞死亡与白细胞介素-7之间的相互作用
J Crit Care Med (Targu Mures). 2025 Apr 30;11(2):132-139. doi: 10.2478/jccm-2025-0003. eCollection 2025 Apr.
4
Trained immunity alleviates the progression of melanoma during sepsis-associated immunoparalysis.训练有素的免疫可减轻脓毒症相关免疫麻痹期间黑色素瘤的进展。
Cell Oncol (Dordr). 2025 Apr 9. doi: 10.1007/s13402-025-01063-8.
5
CD47-amyloid-β-CD74 signaling triggers adaptive immunosuppression in sepsis.CD47-淀粉样蛋白-β-CD74信号通路在脓毒症中触发适应性免疫抑制。
EMBO Rep. 2025 Apr 4. doi: 10.1038/s44319-025-00442-4.
6
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities.髓源性抑制细胞在肝癌中的免疫抑制作用:机制与治疗机遇
Cell Commun Signal. 2025 Mar 27;23(1):155. doi: 10.1186/s12964-025-02170-7.
7
The accumulation of myeloid-derived suppressor cells participates in abdominal infection-induced tumor progression through the PD-L1/PD-1 axis.髓源性抑制细胞的积累通过PD-L1/PD-1轴参与腹部感染诱导的肿瘤进展。
Mol Oncol. 2025 May;19(5):1532-1545. doi: 10.1002/1878-0261.13767. Epub 2025 Jan 21.
8
The Role of PD-1/PD-L1 and IL-7 in Lymphocyte Dynamics and Sepsis Progression: A Biomarker Study in Critically Ill Patients.PD-1/PD-L1和IL-7在淋巴细胞动态变化及脓毒症进展中的作用:一项针对危重症患者的生物标志物研究
Int J Mol Sci. 2024 Nov 24;25(23):12612. doi: 10.3390/ijms252312612.
9
The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer's disease.抑制性免疫检查点受体在阿尔茨海默病发病机制中的作用。
J Mol Med (Berl). 2025 Jan;103(1):1-19. doi: 10.1007/s00109-024-02504-x. Epub 2024 Nov 27.
10
Lactate's impact on immune cells in sepsis: unraveling the complex interplay.脓毒症中乳酸对免疫细胞的影响:揭示复杂的相互作用。
Front Immunol. 2024 Sep 20;15:1483400. doi: 10.3389/fimmu.2024.1483400. eCollection 2024.
利用深度学习预测脓毒症后髓系祖细胞分化的前景。
Chin Med J (Engl). 2019 Aug 5;132(15):1862-1864. doi: 10.1097/CM9.0000000000000349.
4
Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis.持续表达 PD-L1 的 CTL 耐受为小鼠脓毒症提供了一种新的治疗方法。
Theranostics. 2019 Mar 16;9(7):2003-2016. doi: 10.7150/thno.28057. eCollection 2019.
5
Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency.免疫衰老:髓系来源的抑制性细胞(MDSC)在与年龄相关的免疫缺陷中的潜在作用。
Cell Mol Life Sci. 2019 May;76(10):1901-1918. doi: 10.1007/s00018-019-03048-x. Epub 2019 Feb 20.
6
Impaired antigen-specific lymphocyte priming in mice after Toll-like receptor 4 activation via induction of monocytic myeloid-derived suppressor cells.Toll 样受体 4 激活诱导单核细胞来源的髓系抑制细胞后,小鼠的抗原特异性淋巴细胞启动受损。
Eur J Immunol. 2019 Apr;49(4):546-563. doi: 10.1002/eji.201847805. Epub 2019 Feb 1.
7
Challenges in assessing the burden of sepsis and understanding the inequalities of sepsis outcomes between National Health Systems: secular trends in sepsis and infection incidence and mortality in Germany.评估脓毒症负担以及了解国家卫生系统之间脓毒症结局不平等方面的挑战:德国脓毒症和感染发病率及死亡率的长期趋势。
Intensive Care Med. 2018 Nov;44(11):1826-1835. doi: 10.1007/s00134-018-5377-4. Epub 2018 Oct 4.
8
The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process.髓系来源的抑制性细胞(MDSC)在炎症老化过程中的作用。
Ageing Res Rev. 2018 Dec;48:1-10. doi: 10.1016/j.arr.2018.09.001. Epub 2018 Sep 21.
9
Sepsis and septic shock.脓毒症和脓毒性休克。
Lancet. 2018 Jul 7;392(10141):75-87. doi: 10.1016/S0140-6736(18)30696-2. Epub 2018 Jun 21.
10
T cells and their immunometabolism: A novel way to understanding sepsis immunopathogenesis and future therapeutics.T 细胞及其免疫代谢:理解脓毒症免疫发病机制和未来治疗方法的新途径。
Eur J Cell Biol. 2018 Aug;97(6):379-392. doi: 10.1016/j.ejcb.2018.05.001. Epub 2018 May 5.